- Home
- HEPS vs KMTS Comparison
HEPS vs KMTS Comparison
Compare HEPS & KMTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEPS
- KMTS
- Stock Information
- Founded
- HEPS 2000
- KMTS 2014
- Country
- HEPS Turkey
- KMTS United States
- Employees
- HEPS N/A
- KMTS N/A
- Industry
- HEPS Catalog/Specialty Distribution
- KMTS
- Sector
- HEPS Consumer Discretionary
- KMTS
- Exchange
- HEPS Nasdaq
- KMTS NYSE
- Market Cap
- HEPS 883.5M
- KMTS 1.0B
- IPO Year
- HEPS 2021
- KMTS 2025
- Fundamental
- Price
- HEPS $2.88
- KMTS $15.03
- Analyst Decision
- HEPS
- KMTS Buy
- Analyst Count
- HEPS 0
- KMTS 5
- Target Price
- HEPS N/A
- KMTS $27.00
- AVG Volume (30 Days)
- HEPS 367.1K
- KMTS 156.9K
- Earning Date
- HEPS 07-01-2025
- KMTS 07-13-2025
- Dividend Yield
- HEPS N/A
- KMTS N/A
- EPS Growth
- HEPS N/A
- KMTS N/A
- EPS
- HEPS N/A
- KMTS N/A
- Revenue
- HEPS $1,471,066,066.00
- KMTS $52,636,000.00
- Revenue This Year
- HEPS $23.29
- KMTS $113.57
- Revenue Next Year
- HEPS $25.43
- KMTS $42.47
- P/E Ratio
- HEPS N/A
- KMTS N/A
- Revenue Growth
- HEPS 42.87
- KMTS 589.86
- 52 Week Low
- HEPS $1.91
- KMTS $14.15
- 52 Week High
- HEPS $4.05
- KMTS $26.15
- Technical
- Relative Strength Index (RSI)
- HEPS 59.54
- KMTS N/A
- Support Level
- HEPS $2.69
- KMTS N/A
- Resistance Level
- HEPS $2.99
- KMTS N/A
- Average True Range (ATR)
- HEPS 0.10
- KMTS 0.00
- MACD
- HEPS 0.03
- KMTS 0.00
- Stochastic Oscillator
- HEPS 76.60
- KMTS 0.00
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.
About KMTS KESTRA MEDICAL TECHNOLOGIES LTD
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.